Valuation check: SLGL's profit margin is -5.66%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
As of the most recent data (March 2026), SLGL shows a profit margin of -5.66%. That compares with -107.77% in the prior-year period — up 94.7% year over year. That is below the Healthcare sector average of 15.58%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SLGL's profit margin is now -5.66% (was -107.77%) — a 94.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sol-Gel Technologies is outperforming or lagging.
The Healthcare sector average profit margin is about 15.58%. Sol-Gel Technologies is at -5.66%, which is lower that average. That is roughly 136.3% below the sector mean. Use the comparison chart on this page to see how SLGL stacks up against individual peers as well.
That compares with -107.77% in the prior-year period — up 94.7% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Sol-Gel Technologies with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Sol-Gel Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -5.66%) with ownership activity and broader fundamentals.